{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:19:35Z","timestamp":1790864375201,"version":"4.1.0"},"reference-count":165,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127565"],"award-info":[{"award-number":["R01AI127565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI141196"],"award-info":[{"award-number":["R01AI141196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Influenza virus infections represent a serious public health threat and account for significant morbidity and mortality worldwide due to seasonal epidemics and periodic pandemics. Despite being an important countermeasure to combat influenza virus and being highly efficacious when matched to circulating influenza viruses, current preventative strategies of vaccination against influenza virus often provide incomplete protection due the continuous antigenic drift\/shift of circulating strains of influenza virus. Prevention and control of influenza virus infection with vaccines is dependent on the host immune response induced by vaccination and the various vaccine platforms induce different components of the local and systemic immune response. This review focuses on the immune basis of current (inactivated influenza vaccines (IIV) and live attenuated influenza vaccines (LAIV)) as well as novel vaccine platforms against influenza virus. Particular emphasis will be placed on how each platform induces cross-protection against heterologous influenza viruses, as well as how this immunity compares to and contrasts from the \u201cgold standard\u201d of immunity generated by natural influenza virus infection.<\/jats:p>","DOI":"10.3390\/vaccines8030434","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T09:02:48Z","timestamp":1596445368000},"page":"434","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine"],"prefix":"10.3390","volume":"8","author":[{"given":"Christopher E.","family":"Lopez","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology University of Iowa, Iowa City, IA 52242, USA"},{"name":"Department of Pathology, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-6854","authenticated-orcid":false,"given":"Kevin L.","family":"Legge","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology University of Iowa, Iowa City, IA 52242, USA"},{"name":"Department of Pathology, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of Influenza Vaccination in the United States During the 2017\u20132018 Influenza Season","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: Measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.mi.37.100183.002525","article-title":"Immunity to Influenza in Man","volume":"37","author":"Couch","year":"1983","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.4049\/jimmunol.178.4.2448","article-title":"Evidence for Phagocytosis of Influenza Virus-Infected, Apoptotic Cells by Neutrophils and Macrophages in Mice","volume":"178","author":"Hashimoto","year":"2007","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ni1322","article-title":"Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1","volume":"7","author":"Gazit","year":"2006","journal-title":"Nat. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","article-title":"Intrinsic antiviral immunity","volume":"13","author":"Yan","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/vim.2017.0025","article-title":"Adaptive B Cell Responses to Influenza Virus Infection in the Lung","volume":"30","author":"Takahashi","year":"2017","journal-title":"Viral. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.4049\/jimmunol.176.7.4343","article-title":"Type I IFN Receptor Signals Directly Stimulate Local B Cells Early following Influenza Virus Infection","volume":"176","author":"Coro","year":"2006","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","article-title":"T Cell-Dependent B Cell Activation","volume":"11","author":"Parker","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.1801208","article-title":"The Multifaceted B Cell Response to Influenza Virus","volume":"202","author":"Lam","year":"2019","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","article-title":"A Virus Obtained from Influenza Patients","volume":"222","author":"Smith","year":"1933","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, X., Liu, S., Goraya, M.U., Maarouf, M., Huang, S., and Chen, J.-L. (2018). Host Immune Response to Influenza A Virus Infection. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00320"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fmicb.2017.00900","article-title":"Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre","volume":"8","author":"Gould","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01673-18","DOI":"10.1128\/JVI.01673-18","article-title":"Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","article-title":"Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge","volume":"175","author":"Bender","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3389\/fimmu.2019.02351","article-title":"Kinetics and Phenotype of the CD4 T Cell Response to Influenza Virus Infections","volume":"10","author":"Hornick","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_22","first-page":"423","article-title":"The effector T cell response to influenza infection","volume":"386","author":"Hufford","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1038\/ncomms4495","article-title":"FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability","volume":"5","author":"Bradley","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3389\/fimmu.2018.01910","article-title":"Control of Germinal Center Responses by T-Follicular Regulatory Cells","volume":"9","author":"Wing","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A Distinct Function of Regulatory T Cells in Tissue Protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.01069-10","article-title":"Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms","volume":"84","author":"Teijaro","year":"2010","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection","volume":"86","author":"Brown","year":"2012","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-Mediated Cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Guo, H., and Topham, D.J. (2012). Multiple Distinct Forms of CD8+ T Cell Cross-Reactivity and Specificities Revealed after 2009 H1N1 Influenza A Virus Infection in Mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046166"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Weinfurter, J.T., Brunner, K., Capuano, S.V., Li, C., Broman, K.W., Kawaoka, Y., and Friedrich, T.C. (2011). Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002381"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41590-019-0320-6","article-title":"Human CD8+ T cell cross-reactivity across influenza A., B and C viruses","volume":"20","author":"Koutsakos","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1099\/0022-1317-82-11-2697","article-title":"Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection","volume":"82","author":"Heinen","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/iai.29.2.654-662.1980","article-title":"Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity","volume":"29","author":"Yetter","year":"1980","journal-title":"Infect. Immun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/jb.89.1.170-174.1965","article-title":"Induction of Partial Specific Heterotypic Immunity in Mice by A Single Infection with Influenza A Virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J. Bacteriol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ni1530","article-title":"Protective immunity and susceptibility to infectious diseases: Lessons from the 1918 influenza pandemic","volume":"8","author":"Ahmed","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/322662","article-title":"Observations on Mortality during the 1918 Influenza Pandemic","volume":"33","author":"Luk","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ni.2525","article-title":"Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3","volume":"14","author":"Wakim","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1126\/science.1058867","article-title":"Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue","volume":"291","author":"Masopust","year":"2001","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: Local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.1402975","article-title":"Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-\u03b3 Production","volume":"195","author":"McMaster","year":"2015","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaag2031","DOI":"10.1126\/sciimmunol.aag2031","article-title":"Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity","volume":"2","author":"Abboud","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.celrep.2018.08.073","article-title":"Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic Immunity","volume":"24","author":"Varga","year":"2018","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/icb.2017.32","article-title":"Influenza-induced lung Trm: Not all memories last forever","volume":"95","author":"Harty","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Martin, M.D., and Badovinac, V.P. (2018). Defining Memory CD8 T Cell. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02692"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"Onodera","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/vim.2019.0141","article-title":"Resident Memory B Cells","volume":"33","author":"Allie","year":"2020","journal-title":"Viral Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rappuoli, R., and Del Giudice, G. (2011). Correlates of Protection Against Influenza. Influenza Vaccines for the Future, Springer.","DOI":"10.1007\/978-3-0346-0279-2"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Oldstone, M.B.A., and Compans, R.W. (2015). Inactivated and Adjuvanted Influenza Vaccines. Influenza Pathogenesis and Control\u2014Volume II, Springer International Publishing.","DOI":"10.1007\/978-3-319-11158-2"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of Neuraminidase Antibody on Hong Kong Influenza","volume":"301","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine","volume":"129","author":"Couch","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-6-224","article-title":"Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein","volume":"6","author":"Beerli","year":"2009","journal-title":"Virol. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunological assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1016\/j.vaccine.2006.05.051","article-title":"Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses","volume":"24","author":"Berkhoff","year":"2006","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Heiny, A.T., Miotto, O., Srinivasan, K.N., Khan, A.M., Zhang, G.L., Brusic, V., Tan, T.W., and August, J.T. (2007). Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001190"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JVI.02439-15","article-title":"Differential Recognition of Influenza A Viruses by M158\u201366 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues","volume":"90","author":"Kreijtz","year":"2016","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.micinf.2011.01.014","article-title":"The contribution of animal models to the understanding of the host range and virulence of influenza A viruses","volume":"13","author":"Subbarao","year":"2011","journal-title":"Microbes Infect."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Luke, C.J., and Subbarao, K. (2008). The role of animal models in influenza vaccine research. Influenza Vaccines Future, 161\u2013202.","DOI":"10.1007\/978-3-7643-8371-8_8"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/14760584.7.6.783","article-title":"Animal models in influenza vaccine testing","volume":"7","author":"Herberts","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"ref_73","first-page":"E115","article-title":"History and evolution of influenza control through vaccination: From the first monovalent vaccine to universal vaccines","volume":"57","author":"Barberis","year":"2016","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_74","first-page":"147","article-title":"Influenza Virus Infections of the Chick Embryo Lung","volume":"21","author":"Burnet","year":"1940","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI101633","article-title":"Protective Effect of Vaccination Against Induced Influenza A","volume":"24","author":"Francis","year":"1945","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.111.3.387","article-title":"Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8","volume":"111","author":"Kilbourne","year":"1960","journal-title":"J. Exp. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/124.5.473","article-title":"Correlated Studies of a Recombinant Influenza-Virus Vaccine. III. Protection against Experimental Influenza in Man","volume":"124","author":"Couch","year":"1971","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Palese, P., and Kingsbury, D.W. (1983). Practical Applications of Influenza Viral Genetics. Genetics of Influenza Viruses, Springer-Verlag Wien. [1st ed.].","DOI":"10.1007\/978-3-7091-8706-7"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-018-0340-z","article-title":"Current and future influenza vaccines","volume":"25","author":"Yamayoshi","year":"2019","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/infdis\/140.6.844","article-title":"Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection","volume":"140","author":"Beutner","year":"1979","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0264-410X(93)90130-P","article-title":"Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice","volume":"11","author":"Johansson","year":"1993","journal-title":"Vaccine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/134.4.384","article-title":"Comparative Efficacy of Neuraminidase-Specific and Conventional Influenza Virus Vaccines in Induction of Antibody to Neuraminidase in Humans","volume":"134","author":"Kilbourne","year":"1976","journal-title":"J. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/iai.29.3.966-971.1980","article-title":"Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations","volume":"29","author":"Kendal","year":"1980","journal-title":"Infect. Immun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiv196","article-title":"Neuraminidase: Another Piece of the Influenza Vaccine Puzzle","volume":"212","author":"Eckard","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e00417-16","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model","volume":"7","author":"Memoli","year":"2016","journal-title":"Mbio"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1073\/pnas.1311998110","article-title":"Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses","volume":"110","author":"Spensieri","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Budimir, N., de Haan, A., Meijerhof, T., Waijer, S., Boon, L., Gostick, E., Price, D.A., Wilschut, J., and Huckriede, A. (2013). Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063163"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00414-16","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.164.5.2635","article-title":"Th Cell-Deficient Mice Control Influenza Virus Infection More Effectively Than Th- and B Cell-Deficient Mice: Evidence for a Th-Independent Contribution by B Cells to Virus Clearance","volume":"164","author":"Mozdzanowska","year":"2000","journal-title":"J. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/JVI.72.1.882-885.1998","article-title":"Clearance of an Influenza A Virus by CD4+ T Cells Is Inefficient in the Absence of B Cells","volume":"72","author":"Topham","year":"1998","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2010.08.067","article-title":"Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets","volume":"29","author":"Ellebedy","year":"2011","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/jiq144","article-title":"Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets","volume":"203","author":"Chen","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"19763","DOI":"10.2807\/ese.16.02.19763-en","article-title":"Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009\u20132010","volume":"16","author":"Hardelid","year":"2011","journal-title":"Eurosurveillance"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Skowronski, D.M., De Serres, G., Crowcroft, N.S., Janjua, N.Z., Boulianne, N., Hottes, T.S., Rosella, L.C., Dickinson, J.A., Gilca, R., and Sethi, P. (2010). Association between the 2008\u201309 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: Four observational studies from Canada. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000258"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"198ra107","DOI":"10.1126\/scitranslmed.3006637","article-title":"Neutralizing antibodies against previously encountered influenza virus strains increase over time: A longitudinal analysis","volume":"5","author":"Miller","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","article-title":"From Original Antigenic Sin to the Universal Influenza Virus Vaccine","volume":"39","author":"Henry","year":"2018","journal-title":"Trends Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/irv.12142","article-title":"Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: Influence of the route of vaccine administration","volume":"7","author":"Budimir","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Budimir, N., Huckriede, A., Meijerhof, T., Boon, L., Gostick, E., Price, D.A., Wilschut, J., and de Haan, A. (2012). Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: The role of viral membrane fusion activity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030898"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Oldstone, M.B.A., and Compans, R.W. (2015). Live Attenuated Influenza Vaccine. Influenza Pathogenesis and Control\u2014Volume II, Springer International Publishing.","DOI":"10.1007\/978-3-319-11158-2"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4049\/jimmunol.166.1.226","article-title":"IgA Immunodeficiency Leads to Inadequate Th Cell Priming and Increased Susceptibility to Influenza Virus Infection","volume":"166","author":"Arulanandam","year":"2001","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/jcm.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/infdis\/jiu654","article-title":"Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children","volume":"211","author":"Mohn","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"eaam6970","DOI":"10.1126\/sciimmunol.aam6970","article-title":"Resident memory CD8+T cells in the upper respiratory tract prevent pulmonary influenza virus infection","volume":"2","author":"Pizzolla","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.1620194114","article-title":"Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells","volume":"114","author":"Pizzolla","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e85832","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.4049\/jimmunol.1202790","article-title":"Cutting Edge: Rapid Boosting of Cross-Reactive Memory CD8 T Cells Broadens the Protective Capacity of the Flumist Vaccine","volume":"190","author":"Pewe","year":"2013","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1099\/jgv.0.000651","article-title":"Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses","volume":"97","author":"Wang","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"He, X.-S., Holmes, T.H., Sasaki, S., Jaimes, M.C., Kemble, G.W., Dekker, C.L., Arvin, A.M., and Greenberg, H.B. (2008). Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002574"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: Systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy: A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Fan, S., Gao, Y., Shinya, K., Li, C.K., Li, Y., Shi, J., Jiang, Y., Suo, Y., Tong, T., and Zhong, G. (2009). Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000409"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Suguitan, A.L., McAuliffe, J., Mills, K.L., Jin, H., Duke, G., Lu, B., Luke, C.J., Murphy, B., Swayne, D.E., and Kemble, G. (2006). Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030360"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/379045","article-title":"Cross-Reactive H1N1 Antibody Responses to a Live Attenuated Influenza Vaccine in Children: Implication for Selection of Vaccine Strains","volume":"188","author":"Lee","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: Mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: Prime\u2013Boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","article-title":"A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response","volume":"209","author":"Talaat","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1016\/j.vaccine.2014.09.070","article-title":"Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine","volume":"32","author":"Babu","year":"2014","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e01970","DOI":"10.1128\/JVI.01970-17","article-title":"Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes","volume":"92","author":"Jegaskanda","year":"2018","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: Two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/jit178","article-title":"DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults","volume":"208","author":"Khurana","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jiph.2016.09.006","article-title":"Vaccination adherence: Review and proposed model","volume":"9","author":"Abahussin","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0009922809336360","article-title":"Vaccine Adherence in Adolescents","volume":"48","author":"Lehmann","year":"2009","journal-title":"Clin. Pediatrics"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41577-019-0243-3","article-title":"Novel vaccine technologies for the 21st century","volume":"20","author":"Mascola","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.09.4","article-title":"Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara","volume":"8","author":"Rimmelzwaan","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","article-title":"Progress on adenovirus-vectored universal influenza vaccines","volume":"11","author":"Xiang","year":"2015","journal-title":"Human Vaccines Immunother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/s41598-018-26538-7","article-title":"Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera","volume":"8","author":"Yassine","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3389\/fimmu.2019.02997","article-title":"Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance","volume":"10","author":"Mathew","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","article-title":"Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti\u2013Influenza A Antibodies","volume":"52","author":"Sui","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e02284-17","DOI":"10.1128\/mBio.02284-17","article-title":"Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A\/H1N1pdm Virus","volume":"9","author":"Park","year":"2018","journal-title":"Mbio"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.341.6151.1171","article-title":"A Once-in-a-Lifetime Flu Shot?","volume":"341","author":"Cohen","year":"2013","journal-title":"Science"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-018-0063-7","article-title":"Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge","volume":"3","author":"Huizingh","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-019-0147-z","article-title":"Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts","volume":"4","author":"Nachbagauer","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci. Transl Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: Different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol. J."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nsmb.1574","article-title":"Universal epitopes of influenza virus hemagglutinins?","volume":"16","author":"Wang","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/erv.12.70","article-title":"Virus-like particles as universal influenza vaccines","volume":"11","author":"Kang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-010-0547-7","article-title":"Influenza A viruses: Why focusing on M2e-based universal vaccines","volume":"42","author":"Ebrahimi","year":"2011","journal-title":"Virus Genes"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mi.2017.14","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","volume":"11","author":"Eliasson","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"E7758","DOI":"10.1073\/pnas.1805713115","article-title":"Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice","volume":"115","author":"Deng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7774\/cevr.2014.3.1.12","article-title":"New vaccines against influenza virus","volume":"3","author":"Lee","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1901176","DOI":"10.1002\/adhm.201901176","article-title":"Double-Layered M2e-NA Protein Nanoparticle Immunization Induces Broad Cross-Protection against Different Influenza Viruses in Mice","volume":"9","author":"Wang","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41524-017-0050-y","article-title":"Theory, simulations and the design of functionalized nanoparticles for biomedical applications: A Soft Matter Perspective","volume":"3","year":"2017","journal-title":"NPJ Comput. Mater."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S., and Archambault, D. (2019). Nanoparticle-Based Vaccines Against Respiratory Viruses. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00022"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.vaccine.2011.10.105","article-title":"PLGA\/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.)","volume":"30","author":"Fredriksen","year":"2012","journal-title":"Vaccine"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.20092017","article-title":"Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection","volume":"207","author":"Kim","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.immuni.2006.01.015","article-title":"Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration","volume":"24","author":"Zammit","year":"2006","journal-title":"Immunity"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Hiremath, J., Kang, K.-i., Xia, M., Elaish, M., Binjawadagi, B., Ouyang, K., Dhakal, S., Arcos, J., Torrelles, J.B., and Jiang, X. (2016). Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151922"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","article-title":"N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model","volume":"25","author":"Amidi","year":"2007","journal-title":"Vaccine"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3389\/fimmu.2018.01953","article-title":"Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections","volume":"9","author":"Zacharias","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.vaccine.2017.01.019","article-title":"Polyanhydride nanovaccine against swine influenza virus in pigs","volume":"35","author":"Dhakal","year":"2017","journal-title":"Vaccine"},{"key":"ref_161","first-page":"229","article-title":"Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity","volume":"10","author":"Ross","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1016\/j.vaccine.2017.08.021","article-title":"Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M\u2122 adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1166\/jbn.2014.1983","article-title":"Vaccine technologies against avian influenza: Current approaches and new directions","volume":"10","author":"Ross","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s11095-008-9620-5","article-title":"Recent Developments in Cyclic Acetal Biomaterials for Tissue Engineering Applications","volume":"25","author":"Falco","year":"2008","journal-title":"Pharm. Res."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/434\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:53:59Z","timestamp":1760176439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":165,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030434"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030434","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}